Isha Mol

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Optical Coherence Tomography

Drug Administration

Top Venues

Leukemia & lymphoma

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Isha Mol, Yannan Hu, Thomas William LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma. Leukemia & lymphoma (2024)
Isha Mol, Yannan Hu, Thomas William LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma. Leukemia & lymphoma 65 (5) (2024)
Isha Mol, Yannan Hu, Thomas William LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Alex Schepart, Patrick Hlavacek
A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma. Current medical research and opinion (2023)